What is XRTX's dilution risk score?

XRTX currently has a DilutionScore of 71/100, indicating high dilution risk. DilutionWatch monitors XRTX SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

What SEC filings does DilutionWatch track for XRTX?

DilutionWatch tracks 25 SEC filing types for XRTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect XRTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For XRTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for XRTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for XRTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

XRTX Dilution Risk Score: 71/100 (HIGH)

📊 Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

40

📊 Float Risk

77

⚠️ Warrant Exposure

40

🔄Convertible Debt—

🌦️ Dilution Forecast

☀️

Clear

No significant dilution signals

5%

📉 Score Deterioration 10%

• Score in HIGH risk zone (71/100)

🔔 Track XRTX — Get forecast alerts →

💹 Market Data

Market Cap$3.98M

Shares Outstanding12.99M

Float1.37M

Cash$250.3K

Debt$15.1K

Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 100.0% shares (2026Q1 vs prior)

1 institutional holders · 47 shares

#1 TD Waterhouse Canada Inc. 47 shares

📉 Short Interest

Short Interest25.0K

Days to Cover1.7

% of Float1.8%

FINRA data as of Jun 30, 2026

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

EFFECT EFFECT Feb 17, 2026

Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for XRTX Shareholders

XORTX Therapeutics Inc. (XRTX) has a DilutionScore of 71/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch's EDGAR monitoring for XRTX shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for XRTX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for XRTX alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

🔬 More Research for XRTX

📊 XRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XRTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

XRTX — XORTX Therapeutics Inc. Dilution Risk Tracker